Developmental Funds

发展基金

• 批准号: 8340234
• 负责人: KEVIN J. CULLEN
• 金额: $ 12.31万
• 依托单位: UNIVERSITY OF MARYLAND BALTIMORE
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-08-24 至 2016-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8340234
• 关键词: American Cancer Society; Area; Award; Budgets; Cancer Center Support Grant; Cancer Grant Supplements (P30); Development; Direct Costs; Discipline; Epidemiology; Faculty; Funding; Funding Mechanisms; Grant; Ice; Image; Interdisciplinary Study; Investments; Leadership; Maryland; Pain; Peer Review; Pilot Projects; Process; Recruitment Activity; Reporting; Research; Research Personnel; Scientist; Services; Site Visit; Strategic Planning; United States National Institutes of Health; Universities; base; high throughput screening; meetings; molecular pathology; programs; ranpirnase

7.5.1 Overall Description UMGCC requests developmental funds amounting to $260,000, or 9 percent of the total direct costs of its budget. These funds are essential for UMGCC to: ¿ Pilot projects for Developing Pain Studies Program ($50,000) ¿ Provide funds to support the establishment of three new developing shared sen/ices ($60,000) ¿ Fund five new pilot projects for Shared Services annually ($50,000) ¿ Conduct recruiting for epidemiology ($100,000) Developmental funds will be necessary for UMGCC's leadership to recruit faculty in high-priority areas established by the strategic planning process. In addition, the promotion of Interdisciplinary research will require seed money for pilot grant support in areas that bring investigators of different disciplines together and utilize UMGCC's shared services. Finally, core grant support will be necessary for further establishing essential shared services, such as imaging, molecular pathology, and high-throughput screening. Developmental funds from the P30 Grant will continue to be leveraged by additional funds from Maryland's CRFP and the American Cancer Society (ACS) over the next 5 years. Allocation of developmental funds will be through (a) the strategic-planning process internal to UMGCC, with peer review and approval of the UMGCC Research Council; and (b) recruitment in predefined areas that meet the criteria established by senior leadership. The 2008 NCI Site Visit Report gave this section an Excellent to Very Good rating. NCI thought that requests were well justified and the monies would augment the substantial investment that UMGCC had made in developing programs and shared services. NCI noted the description of the planned usage of these combined investments lacked adequate focus and prioritization of two developing programs and four additional shared services.

7.5.1 总体描述 UMGCC 要求提供 260,000 美元的发展资金，占其预算总直接成本的 9%。这些资金对于 UMGCC 来说至关重要： ¿发展疼痛研究计划试点项目（50,000 美元） ¿提供资金支持建立三个新发展的共享服务（60,000 美元） ¿每年资助五个新的共享服务试点项目（50,000 美元） ¿进行流行病学招募（100,000 美元） UMGCC 的领导层将需要在战略规划过程中确定的高优先领域招聘教员，此外，促进跨学科研究将需要种子资金，以在将不同学科的研究人员聚集在一起并利用的领域提供试点拨款支持。最后，核心拨款支持对于进一步建立必要的共享服务是必要的，例如成像、分子病理学和高通量筛选。马里兰州的 CRFP 和美国癌症协会 (ACS) 未来 5 年的发展资金将通过 (a) 分配。 UMGCC 内部的战略规划流程，并得到 UMGCC 研究委员会的同行评审和批准；以及 (b) 符合高级领导层制定标准的预定义领域的招聘。 2008 年 NCI 实地考察报告将此部分评为“优秀”至“非常好”。 NCI 认为这些请求是合理的，这些资金将增加 UMGCC 在开发项目和共享服务方面的大量投资，NCI 指出，对这些合并投资的计划用途的描述缺乏足够的重点和优先顺序。开发计划和四项额外的共享服务。